Evaluation of phytochemicals from Azadirachta indica for drug-like properties: A computational insight into natural product-based drug discovery
DOI:
https://doi.org/10.70066/jahm.v13i8.2117Keywords:
Azadirachta indica, phytochemicals, drug-likeness, Lipinski’s Rule of Five, bioavailability, computational drug discoveryAbstract
Introduction: The growing interest in natural products for drug discovery has strengthened the exploration of various phytochemicals from traditional medicinal plants like Azadirachta indica (Neem), known for its excellent therapeutic benefits. Methodology: This current study uses computerised tools to appraise drug-like potential for the medicinal plant Azadirachta indica-derived phytochemicals. Few parameters, such as molecular weight, lipophilicity (Log P), hydrogen bond donors or acceptors, and Drug Likeness score, were analysed using IMPPAT and Molsoft L.L.C database highlighting on Lipinski’s Rule of Five. Results: Phytochemical compounds such as nimbin, nimbolide, azadirachtin, and quercetin exhibited favourable drug-like properties and better oral bioavailability. Major phytochemicals that are analysed have complied with standards of drug-likeness, reinforcing their viability as potential orally administered therapeutic drug candidates. Conclusion: These results emphasize the value of phytochemicals present in Azadirachta indica for modern drug development and emphasize the usefulness of computerised tools in the early stage of drug screening and evaluation for future pharmacological studies.
References
Bhowmik D, Chiranjib YJ, Tripathi KK, Kumar KS. Herbal remedies of Azadirachta indica and its medicinal application. Journal of Chemical and Pharmaceutical Research. 2010;2:62–72. Available from: https://www.mchemist.com/herboglo/pdf/2%20neem.pdf.
Kharwar RN, Sharma VK, Mishra A, Kumar J, Singh DK, Verma SK, et al. Harnessing the phyto therapeutic treasure troves of the ancient medicinal plant Azadirachta indica (Neem) and associated endophytic microorganism. Planta Med. 2020;86(11):906–940. Available from: https://doi.org/10.1055/a-1195-0144
Devi J, Sharma RB. Medicinal importance of Azadirachta indica: An overview. Journal of Drug Delivery and Therapeutics. 2023;13(6):599–602. Available from: https://doi.org/10.22270/jddt.v13i6.5992
Sliwoski G, Kothiwale S, Meiler J, Lowe EW. Computational methods in drug discovery. Pharmacol Rev. 2014;66(1):334–395. Available from: https://doi.org/10.1124/pr.112.007336
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews. 1997;23(1–3):3–25. https://doi.org/10.1016/S0169-409X(96)00423-1.
Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nature Reviews Drug Discovery. 2004;3(11):935–49. https://doi.org/10.1038/nrd1549.
Ahmad A, Khan M, Hadi SM, Shukla Y. Molecular targets of Neem (Azadirachta indica) and its bioactive compounds in cancer: preclinical and clinical studies. Life Sciences. 2018;192:110–23. https://doi.org/10.1016/j.lfs.2017.11.012.
Prashanth J, Ramesh S. Molecular docking and dynamics simulation studies of nimbolide from Azadirachta indica against cancer target proteins. Computational Biology and Chemistry. 2021;90:107378. https://doi.org/10.1016/j.compbiolchem.2021.107378.
Roy A, Bharadvaja N. In silico study on anticancer potential of Azadirachta indica phytochemicals targeting PI3K/AKT/mTOR pathway. Journal of Pharmacognosy and Phytochemistry. 2017;6(5):1181–7. Available from: https://www.phytojournal.com/
Ekins S, Mestres J, Testa B. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. British Journal of Pharmacology. 2007;152(1):9–20. https://doi.org/10.1038/sj.bjp.0707305.
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews. 2001;46(1–3):3–26. https://doi.org/10.1016/S0169-409X(00)00129-0.
Mohanraj K, Karthikeyan BS, Vivek-Ananth RP, Chand RP, Aparna SR, Mangalapandi P, et al. IMPPAT: a curated database of Indian medicinal plants, phytochemistry and therapeutics. Scientific Reports. 2018;8(1):4329. https://doi.org/10.1038/s41598-018-22631-z.
Sliwoski G, Kothiwale S, Meiler J, Lowe EW. Computational methods in drug discovery. Pharmacological Reviews. 2014;66(1):334–95. https://doi.org/10.1124/pr.112.007336.
Sophia J, Kumar KKKT, Kowshik J, Mishra R, Nagini S. Nimbolide, a neem limonoid, inhibits phosphatidylinositol 3 kinase and activates GSK 3β in a hamster model of oral carcinogenesis via strong molecular docking interactions with PI3K, Akt, ERK, and GSK 3β. Scientific Reports. 2016;6:22192. Available from: https://www.nature.com/articles/srep22192.
Frenț O-D, Dragu D, Movileanu L, Pînzaru I, Danciu C. A systematic review: quercetin—secondary metabolite of Lagerstroemia speciosa (L.) Pers. Int J Mol Sci. 2024;25(22):12091. Available from: https://doi.org/10.3390/ijms252212091
Ghorbani A. Mechanisms of antidiabetic effects of flavonoid rutin. Biomed Pharmacother. 2017;96:305-12. https://doi.org/10.1016/j.biopha.2017.09.001
Qian XP, Liu Y, Meng F, Guo Y, Li W, Ma Y, et al. Corosolic acid and its structural analogs: a systematic review. Phytomedicine. 2021;91:153696. Available from: https://doi.org/10.1016/j.phymed.2021.153696
Ong YS, Khaw KY, Tan LTH, Goh BH, Chan CK. An overview of the bioactivities of gedunin. In: Ozturk M, Hakeem KR, editors. Plant and Human Health, Volume 3. Cham: Springer; 2019. p. 563-86. Available from: https://doi.org/10.1007/978-3-030-54027-2_16
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Madduru Muni Haritha, Prashanth G.Jadar
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.
